Document:

Neurokine Pharmaceuticals Inc.: Exhibit 10.1 - Filed by newsfilecorp.com

	Neurokine Pharmaceuticals Inc. 
	1275 West 6th Avenue,
      Vancouver, BC, Canada V6H 1A6 
	Private Placement Subscription Agreement 
	for Non U.S. Residents 

	 	 	 	 
	Name of
      Purchaser 	Hassan Salari 	  	(the
      “Purchaser”) 
	 	 	 	 
	Tax ID or SIN 	 	  	     
	 	 	 	 
	Address 	1517
      West 58th Avenue 	  	     
	 	 	 	 
	City 	Vancouver 	  	     
	 	 	 	 
	Province 	British Columbia 	  	     
	 	 	 	 
	Country 	Canada    	  	     
	 	 	 	 
	Postal Code 	V6P
      1W6 	  	     
	 	 	 	 
	Telephone 	 	 	 
	 	 	 	 
	Date 	July
      29, 2010 	  	     
	 	 	 	 
	Payment
      Method 	 	  	     
	  	 	  	  
	Number of Units
      Purchased 	4,000,000 	x US$0.05 = 	$7,500 
	Each Unit consists
      of one share of our common
      stock and one common stock purchase warrant 	(the “Units”) 	  	Subscription Price 
	  	 	  	  
	 	 	 
	Signature of Purchaser 	     	  

The Purchaser subscribes for and agrees to purchase from
Neurokine Pharmaceutical Inc., a British Columbia (the "Company"), units with
each unit (the “Unit”) consisting of one share of our common stock and one
warrant, to purchase a quarter (1⁄4) of a share of common stock of the Company at
an exercise price of US$0.05 per share and in accordance other terms as set out
in Schedule “D” hereto , to be recorded in the name of the Purchaser at the
address set out above, all on the terms and subject to the conditions set forth
in Schedule “A” attached hereto.

These securities have not been registered under the Securities
Act of 1933 (the “U.S. Securities Act”) and may not be offered or sold in the
United States or to U.S. persons (other than distributors) unless the securities
are registered under the Act, or an exemption from the registration requirements
of the Act is available. Hedging transactions involving these securities may not
be conducted unless in compliance with the U.S. Securities Act.

The foregoing Subscription is accepted for and on behalf of
Neurokine Pharmaceuticals Inc.:

	By: 		Date: 	July           
      , 2010 
	 	Ahmad Doroudian, President 	  	 

1

Schedule “A”

     In consideration of the covenants
and agreements herein, and the payment of one dollar made by each party to the
other, the receipt and sufficiency of which is acknowledged by each party, the
parties agree as follows:

Delivery of Documents and Funds

		
      The Subscriber hereby delivers to the Company:

	 	 
	1. 	
      a completed and executed copy of this
Agreement;

	 	 
	2. 	
      for all Subscribers: a completed and executed Investor
      Exemptions Questionnaire attached as Schedule “B” and in the case of a
      subscription for the Units by Subscriber acting as trustee or agent for a
      principal, the Subscriber shall provide the Company an Accredited Investor
      Questionnaire in the form set forth in Schedule “B” for each trust,
      beneficial owner and/or principal for which the Subscriber is acting as
      trustee or agent;

	 	 
	3. 	
      if the Subscriber is a U.S. Person, additionally: a
      completed and executed Accredited Investor Questionnaire attached as
      Schedule “C” and in the case of a subscription for the Units by Subscriber
      acting as trustee or agent for a principal, the Subscriber shall provide
      the Company an Accredited Investor Questionnaire in the form set forth in
      Schedule “C” for each trust, beneficial owner and/or principal for which
      the Subscriber is acting as trustee or agent; and

	 	 
	4. 	
      a certified check or bank draft for the Funds made
      payable to “Neurokine Pharmaceuticals Inc.”

Closing

     The closing of the transactions
contemplated by this Agreement (the “Closing”) will take place as subscriptions
are received by the Company.

     At Closing, the Company will
deliver to the Subscriber the certificates representing the Units and an
agreement representing the Warrants purchased by the Subscriber registered in
the name of the Subscriber or as directed on the cover page of this Agreement.

Subscriber’s Representations, Warranties, Covenants,
Acknowledgements and Agreements

	1. 	
      The Subscriber represents and warrants to the Company,
      and acknowledges that the Company is relying on these representations and
      warranties to, among other things, ensure that it is complying with all of
      the applicable securities legislation, that:

	 	 	 	 
		(a) 	
      the Subscriber is purchasing as principal and is either
      :

	 	 	 	 
			(i) 	
      not a U.S. person and is not acquiring the Units for the
      account or benefit of any U.S. person; OR

	 	 	 	 
			(ii) 	
      a U.S. person who is purchasing the Units in a
      transaction that does not require registration under the U.S. Securities
      Act.

	 	 	 	 
		(b) 	
      if the Subscriber is a resident of an “International
      Jurisdiction” (which means a jurisdiction other than British Columbia),
      then:

2

	 	(i) 	
      the Subscriber is knowledgeable of, or has been
      independently advised as to, the applicable securities legislation of the
      International Jurisdiction which would apply to this subscription, if
      there are any;

	 	 	 
	 	(ii) 	
      the Subscriber is purchasing the Units pursuant to
      exemptions under the securities legislation of that International
      Jurisdiction or, if such is not applicable, the Subscriber is permitted to
      purchase the Units under the applicable securities legislation of the
      International Jurisdiction without the need to rely on exemptions;
    and

	 	 	 
	 	(iii) 	
      the applicable securities legislation does not require
      the Company to make any filings or seek any approvals of any kind
      whatsoever from any regulatory authority of any kind whatsoever in the
      International Jurisdiction; and

the Subscriber will, if requested by
the Company, deliver to the Company a certificate or opinion of local counsel
from the International Jurisdiction which will confirm the matters referred to
in subparagraphs (ii) and (iii) above to the satisfaction of the Company, acting
reasonably;

		(c) 	
      if the Subscriber is a U.S. Person (as defined under
      Regulation S promulgated under the United States Securities Act of 1933,
      as amended (the “U.S. Securities Act”), which definition includes an
      individual resident in the United States and an estate or trust of which
      any executor or administrator or trustee, respectively, is a U. S.
      Person), then:

	 	 	 	 
			
      (i) 
	the Subscriber understands that the Units have not been and
      will not be registered under the U.S. Securities Act or any applicable
      state securities laws, and that the sale contemplated hereby is being made
      in reliance on an exemption from registration pursuant to Section 4(6) of
      the U.S. Securities Act to accredited investors (as that term is defined
      in Rule 501(a) of Regulation D under the U.S. Securities Act, (an
      “Accredited Investor”)); AND
	 	 	 	 
			
      (ii) 
	the Subscriber agrees that if it decides to
      offer, sell or otherwise transfer any of the Units, it will not offer,
      sell or otherwise transfer any of such Units directly or indirectly,
      unless:
	 	 	 	 
	 			
      (A) 
	
      the Company’s securities are publicly traded on a
      national securities exchange, the Nasdaq Stock Market or the OTC Bulletin
      Board; or

	 	 	 	 
	 			
      (B) 
	
      the Company consents, in its sole discretion, in writing
      to such transfer and the transfer is made outside the United States in a
      transaction meeting the requirements of Rule 904 of Regulation S under the
      U.S. Securities Act (“Regulation S”) (or such successor rule or regulation
      then in effect), if applicable, and in compliance with applicable state
      securities laws and it has prior to such sale furnished to the Company an
      opinion of counsel, in a form reasonably satisfactory to the Company
      regarding compliance with Rule 904 and any applicable state securities
      laws; or the transfer is made pursuant to an exemption from the
      registration requirements under the U.S. Securities Act provided by Rule
      144A or 144 thereunder, if available, and in accordance with any
      applicable state securities laws and it has prior to such sale furnished
      to the Company an opinion of counsel, in a form reasonably satisfactory to the Company
regarding compliance with Rule 144A or 144, as applicable, and any applicable
state securities laws; AND

3

	 	(iii) 	
      the Subscriber understands and acknowledges that upon the
      issuance thereof, and until such time as the same is no longer required
      under applicable requirements of the U.S. Securities Act or applicable
      state securities laws, the certificates representing the Units shall bear,
      the following legends:

	 	 	 
	 		
      If the Subscriber is a Canadian resident:

	 	 	 
	 		
      “THE SECURITIES REPRESENTED HEREBY HAVE BEEN OFFERED IN
      AN OFFSHORE TRANSACTION TO A PERSON WHO IS NOT A U.S. PERSON (AS DEFINED
      HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF
      1933, AS AMENDED (THE “1933 ACT”).

	 	 	 
	 		
      NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN
      REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND,
      UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY,
      IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN
      ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT,
      PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR
      PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN
      ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING
      TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN
      COMPLIANCE WITH THE 1933 ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS
      DEFINED BY REGULATION S UNDER THE 1933 ACT.”

	 	 	 
	 		
      and

	 	 	 
	 		
      “UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE
      HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT
      IS FOUR MONTHS AND A DAY AFTER THE LATER OF (i) THE PURCHASE OF THESE
      SECURITIES AND (ii) THE DATE THE ISSUER BECAME A REPORTING ISSUER IN ANY
      PROVINCE OR TERRITORY.”

	 	 	 
	 		
      If the Subscriber is a U.S. resident:

	 	 	 
	 		
      “NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN
      REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE
      “1933 ACT”), OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED,
      MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES
      (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE
      PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE
      REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE
      EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS
      INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH
      THE 1933 ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY
      REGULATION S UNDER THE 1933 ACT.”

4

and if the Units are being sold
outside of the United States in accordance with Rule 904 of Regulation S, the
legend Regulations S legend may be removed by providing a declaration to the
Company’s registrar and transfer agent in such form as the Company may
prescribe, including an opinion of counsel that such sale complies with the
requirements of the U.S. Securities Act;

		(d) 	
      the Subscriber acknowledges that:

	 	 	 	 
			(i) 	
      no securities commission or similar regulatory authority
      has reviewed or passed on the merits of the Units;

	 	 	 	 
			(ii) 	
      there is no government or other insurance covering the
      Units;

	 	 	 	 
			(iii) 	
      there are risks associated with the purchase of the
      Units;

	 	 	 	 
			(iv) 	
      there are restrictions on the Subscriber’s ability to
      resell the Units and it is the responsibility of the Subscriber to find
      out what those restrictions are and to comply with them before selling the
      Units;

	 	 	 	 
			(v) 	
      the Subscriber is restricted from using certain of the
      civil remedies available under the applicable securities
    legislation;

	 	 	 	 
			(vi) 	
      the Subscriber may not receive information that might
      otherwise be required to be provided to the Subscriber under the
      applicable securities legislation if the exemptions were not being
      used;

	 	 	 	 
			(vii) 	
      the Company is relieved from certain obligations that
      would otherwise apply under the applicable securities legislation if the
      exemptions were not being used; and

	 	 	 	 
			(viii) 	
      the Company is relying on exemptions in applicable
      securities laws from the requirements to provide the Subscriber with a
      prospectus and to sell the Units through a person registered to sell
      securities and the Subscriber understands that the exemptions release the
      Company from the requirements to provide the Subscriber with a prospectus
      and to sell Stock through a person registered to sell securities under the
      Securities Act (British Columbia) and, as a consequence of
      acquiring Stock pursuant to those exemptions, certain protections, rights
      and remedies provided by the Securities Act (British Columbia),
      including statutory rights of rescission or damages, will not be available
      to the Subscriber;

	 	 	 	 
	(e) 	
      the Subscriber is subscribing for the Units as principal
      for its own account and not for the benefit of any other person (within
      the meaning of applicable securities laws) and not with a view to resale
      or distribution of all or any of the Units or, if it is not subscribing as
      principal, it acknowledges that the Company may be required by law to
      disclose to certain regulatory authorities the identity of each beneficial
      Subscriber for the Units for whom it is acting;

	 	 	 	 
	(f) 	
      in the case of a subscription for the Units by the
      Subscriber acting as trustee or agent (including, for greater certainty, a
      portfolio manager or comparable adviser) for another person or entity, the
      Subscriber is duly authorized to execute and deliver this Subscription
      Agreement and all other necessary documentation in connection with such
      subscription on behalf of each such beneficial person, each of whom is
      subscribing for its own account, not for the benefit of any other person
      and not with a view to the resale or distribution of the Units and
      this Agreement has been duly authorized, executed and delivered by or on
      behalf of and constitutes a legal, valid and binding agreement of, such
      principal, and the Subscriber acknowledges that the Company may be
      required by law to disclose the identity of each beneficial Subscriber for
  whom the Subscriber is acting;

5

	(g) 	
      the offer and sale of these Units was not accomplished by
      an advertisement or other general solicitation (and the Subscriber has not
      attended any seminar or meeting whose attendees have been invited by
      general solicitation or general advertisement) and the Subscriber was not
      induced to purchase the Units as a result of any advertisement or general
      solicitation made by the Company; and

	 	 
	(h) 	
      if the Subscriber is a corporation, the Subscriber is a
      valid and subsisting corporation and was not organized for the purpose of
      acquiring the Units, has the necessary corporate capacity and authority to
      execute and deliver this Agreement and to observe and perform its
      covenants and obligations hereunder and has taken all necessary corporate
      action in respect thereof, or, if the Subscriber is an individual, a
      partnership, syndicate, trust or other form of unincorporated
      organization, the Subscriber has the necessary legal capacity and
      authority to execute and deliver this Agreement and to observe and perform
      its covenants and obligations hereunder and has obtained all necessary
      approvals in respect thereof, and, in either case, upon the Company
      executing and delivering this Agreement, this Agreement will constitute a
      legal, valid and binding contract of the Subscriber enforceable against
      the Subscriber in accordance with its terms and neither the agreement
      resulting from such acceptance nor the completion of the transactions
      contemplated hereby conflicts with, or will conflict with, or results, or
      will result, in a breach or violation of any law applicable to the
      Subscriber, any constating documents of the Subscriber or any agreement to
      which the Subscriber is a party or by which the Subscriber is
  bound;

	2. 	
      this subscription is given for valuable consideration and
      may not be withdrawn or revoked by the Subscriber;

	 	 
	3. 	
      the Company may for any reason, at any time before
      acceptance of this Agreement, terminate the offering of Units and, upon
      termination, the Company will return the Funds to the Subscriber without
      interest or deduction;

	 	 
	4. 	
      the Units will be subject to the following resale or
      transfer restrictions:

	 	(a) 	
      the Units will be subject to resale restrictions under
      applicable securities legislation including resale restrictions under the
      Securities Act (British Columbia) which include a hold period of at
      least four months;

	 	 	 
	 	(b) 	
      the Subscriber will not be able to resell, assign or
      otherwise dispose of the Units unless they are subsequently distributed
      under a prospectus, registration statement or in compliance with all
      applicable resale restrictions;

	 	 	 
	 	(c) 	
      the Company may be required to legend the certificates
      representing the Units regarding these and any other restrictions on
      resale; and

	 	 	 
	 	(d) 	
      while the Company has agreed use its commercially
      reasonably efforts to include the Units in a registration statement
      covering the resale of same pursuant to “piggy-back” registration rights,
      the Company is under no obligation to file a registration statement, or
      register the resale of the Units under a prospectus or registration
      statement, or assist the Subscriber in complying with any
  exemption from the prospectus or registration
statement requirements or resale restrictions set out under applicable
securities legislation; provided, however, that in connection with any
underwritten public offering by the Company, during the period of duration (not
to exceed 180 days) specified by the Company and an underwriter of common stock
of the Company following the effective date of a registration statement of the
Company with respect to such offering, the Subscriber will not, to the extent
requested by the Company and such underwriter, directly or indirectly sell,
offer to sell, contract to sell (including, without limitation, any short sale),
grant any option to purchase, pledge, or otherwise transfer or dispose of (other
than to donees who agree to be similarly bound) any of the Units of the Company
held by the Subscriber at any time during such period except common stock
included in such registration. If requested by such underwriter, the Subscriber
agrees to execute a lock-up agreement in such form as the underwriter may
reasonably propose.

6

	5. 	
      the Subscriber will not resell, assign or otherwise
      dispose of the Units other than in accordance with all applicable
      securities legislation and the requirements of any exchange or
      over-the-counter market upon which any securities of the Company are then
      listed;

	 	 
	6. 	
      the Subscriber’s investment in the Units is speculative
      and involves a high degree of risk, substantial financing for the Company
      may be required in the future, and there is no assurance that any such
      additional financing can be obtained;

	 	 
	7. 	
      the Subscriber is able to bear the economic risks of an
      investment in the Units, including, without limiting the generality of the
      foregoing, the risk of losing part or all of the Funds, and the inability
      to sell, convert, exchange or transfer the Units at a price which would
      enable the Subscriber to recoup his, her or its investment in the
      Units;

	 	 
	8. 	
      other than any persons to whom the Company has agreed to
      pay a brokerage or finder’s fee, there is no person acting or purporting
      to act in connection with the transactions contemplated herein who is
      entitled to any brokerage or finder’s fee. If any person establishes a
      claim that any fee or other compensation is payable in connection with
      this subscription for the Units, the Subscriber covenants to indemnify and
      hold harmless the Company with respect thereto and with respect to all
      costs reasonably incurred in the defence thereof;

	 	 
	9. 	
      the Subscriber, and each beneficial person for whom it is
      contracting hereunder, have been advised to consult their own legal
      advisors with respect to trading in the Units and with respect to the
      resale restrictions imposed by the securities laws of the state in which
      the Subscriber resides, the U.S. Securities Act and the rules and
      regulations thereunder, and any other applicable securities laws, and
      acknowledges that no representation has been made respecting the
      applicable hold periods or other resale restrictions applicable to such
      securities which restrict the ability of the Subscriber (or others for
      whom it is contracting hereunder) to resell such securities, that the
      Subscriber (or others for whom it is contracting hereunder) is solely
      responsible to find out what these restrictions are and the Subscriber is
      solely responsible (and the Company is not in any way responsible) for
      compliance with applicable resale restrictions and the Subscriber is aware
      that it (or beneficial persons for whom it is contracting hereunder) may
      not be able to resell such securities except in accordance with limited
      exemptions under the securities laws (including the U.S. Securities Act)
      and other applicable securities laws;

	 	 
	10. 	
      the Subscriber will execute, deliver, file and otherwise
      assist the Company in filing, any report, undertaking or document with
      respect to the purchase, sale, conversion or exchange of the Units as
      required by counsel for the Company;

7

	11. 	
      the Subscriber hereby authorizes the Company to correct
      any minor errors in, or complete any minor information missing from, any
      document which has been executed by the Subscriber and delivered to the
      Company with respect to this Subscription;

	 	 
	12. 	
      if, for any reason, the offering of Units is terminated
      or the Subscriber’s subscription is rejected, the Subscriber will have no
      claims against the Company, its directors and officers, shareholders,
      agents, advisors, and affiliates and shall have no interest in the Company
      or in any property or assets of the Company;

	 	 
	13. 	
      Subscriber acknowledges that there are risks associated
      with the purchase of and investment in the Units and the Subscriber, and
      each beneficial person for whom it is contracting hereunder, is
      knowledgeable, sophisticated and experienced in business and financial
      matters and is capable of evaluating the merits and risks of an investment
      in the Units, fully understands the restrictions on resale of the Units
      and is able to bear the economic risk of an investment in the
  Units;

	 	 
	14. 	
      the Subscriber is familiar with the aims and objectives
      of the Company and the proposed use of the proceeds received by the
      Company from the sale of the Units and is aware of the risk and other
      characteristics of an investment in the Units;

	 	 
	15. 	
      in evaluating the merits and risks of an investment in
      the Units, the Subscriber has relied solely upon the advice of his, her or
      its legal, tax and investment advisors and not any oral or written
      statement made by, or on behalf of, the Company or its advisors;

	 	 
	16. 	
      THE SUBSCRIBER IS RESPONSIBLE FOR OBTAINING HIS, HER OR
      ITS OWN LEGAL, INVESTMENT AND TAX ADVICE;

	 	 
	17. 	
      the Company may pay a commission or fee in respect of the
      sale of the Units;

	 	 
	18. 	
      the Subscriber and each beneficial person for whom it is
      acting is a resident in the jurisdiction set out on the face page of this
      Agreement. Such address was not created and is not used solely for the
      purpose of acquiring the Units and the Subscriber and any beneficial
      person was solicited to purchase in such jurisdiction and is acquiring the
      Units for its own account or for the account of another Accredited
      Investor (as defined in Rule 501(a) of Regulation D under the U.S.
      Securities Act) over which the Subscriber exercises sole investment
      discretion, and as to which the Subscriber has the authority to make the
      statements set forth in this Agreement, in each case not with a view to,
      or for offer or sale in connection with, any resale, distribution or other
      disposition of the Units in any transaction that would be in violation of
      the U.S. Securities Act or applicable state securities laws; and

	 	 
	19. 	
      The Subscriber, if an individual, is at least 18 years of
      age. If Subscriber is an association or entity, each individual member of
      the association or entity is at least 18 years of age. If Subscriber is
      acquiring the Units for the account of another person, such person, if an
      individual is at least 18 years of age, or if such person is an
      association or entity, each individual member of the association or entity
      is over 18 years of age.

8

Reliance Upon Representations, Warranties, Covenants,
Acknowledgements and Agreements

     The Subscriber acknowledges that
the representations, warranties, covenants, acknowledgements and agreements
contained in this Agreement are made with the intent that they may be relied
upon by the Company, and the Subscriber hereby agrees to indemnify the Company,
its officers, directors, employees and agents against all losses, claims, costs,
expenses and damages or liabilities which they may suffer or incur caused or
arising from their reliance thereon. The Subscriber covenants that the foregoing
representations, warranties, covenants, acknowledgements and agreements will be
true at the time of execution of this Agreement and at the date of issuance of
the Units and agrees that they shall survive the purchase by the Subscriber of
the Units.

Representations and Warranties of the Company

The Company represents and warrants that:

	 	(a) 	
      the Company is a valid and subsisting corporation duly
      incorporated and in good standing under the laws of the jurisdiction in
      which it is incorporated;

	 	 	 
	 	(b) 	
      the Company is duly registered and licensed to carry on
      business in the jurisdictions in which it carries on business or owns
      property where required under the laws of those jurisdictions;

	 	 	 
	 	(c) 	
      the Company will reserve or set aside sufficient shares
      in its treasury to issue the Shares and any shares of common stock
      resulting from exercising the Warrants;

	 	 	 
	 	(d) 	
      the issue and sale of the Shares by the Company does not
      and will not conflict with, and does not and will not result in a breach
      of, any of the terms of the Company’s incorporating documents or any
      agreement or instrument to which the Company is a party; and

	 	 	 
	 	(e) 	
      this Agreement has been or will be by the Closing, duly
      authorized by all necessary corporate action on the part of the Company,
      and the Company has full corporate power and authority to undertake the
      offering.

Indemnity

     The Subscriber agrees to
indemnify and hold harmless the Company and its directors, officers, employees,
agents, advisers and shareholders from and against any and all loss, liability,
claim, damage and expense whatsoever including, but not limited to, any and all
fees, costs and expenses whatsoever reasonably incurred in investigating,
preparing or defending against any litigation, administrative proceeding or
investigation commenced or threatened or any claim whatsoever arising out of or
based upon any representation or warranty of the Subscriber contained herein or
in any document furnished by the Subscriber to the Company in connection
herewith being untrue in any material respect or any breach or failure by the
Subscriber to comply with any covenant or agreement made by the Subscriber
herein or in any document furnished by the Subscriber to the Company in
connection herewith.

9

Offering

     This offering of securities forms
part of a larger offering of similar securities being made by the Company. The
offering is not subject to any minimum subscription level and the Subscriber
acknowledges that he, she or it may be the only subscriber to the offering.

Costs

     The Subscriber acknowledges and
agrees that all costs and expenses incurred by the Subscriber, including any
fees and disbursements of any advisor retained by the Subscriber relating to the
purchase of the Units, shall be borne by the Subscriber.

Survival

     The representations, warranties,
covenants, acknowledgements and agreements contained in this Agreement shall
survive the Closing and will continue in full force and effect and be binding
upon the Subscriber notwithstanding any subsequent disposition by the Subscriber
of the Units.

Enurement

     This Agreement will enure to the
benefit of and be binding upon the Subscriber and the Company and their
respective heirs, administrators, representatives, successors and permitted
assigns.

Assignment

This Agreement is not transferable or assignable.

Registration

     The Company shall make all
reasonable efforts to have the Units registered with the Securities and Exchange
Commission within 60 days of the closing of this Agreement. 

Counterparts

     This Agreement may be executed in
as many counterparts as may be necessary and by facsimile, each of such
counterparts so executed will be deemed to be an original and such counterparts
together will constitute one and the same instrument.

10

Schedule “B”

INVESTOR EXEMPTIONS QUESTIONNAIRE

The purpose of this Questionnaire is to assure the Company that
the Subscriber will meet certain requirements for the registration and
prospectus exemptions provided for under National Instrument 45-106 (“NI
45-106”) in respect to the issuance of the Units pursuant to the Agreement. The
Company will rely on the information contained in this Questionnaire for the
purposes of such determination.

The undersigned Subscriber covenants, represents and warrants
to the Company that:

	1. 	they are (check one or more of the following
      boxes): 

	(a) 	
      a director, executive officer, employee or control person
      of the Company or an affiliate of the Company
	[     ] 
	 	 	 
	(b) 	
      a spouse, parent, grandparent, brother, sister or child
      of a director, executive officer or control person of the Company or an
      affiliate of the Company
	[     ] 
	 	 	 
	(c) 	
      a parent, grandparent, brother, sister or child of the
      spouse of a director, executive officer or control person of the Company
      or an affiliate of the Company
	[     ] 
	 	 	 
	(d) 	
      a close personal friend of a director, executive officer
      or control person of the Company or an affiliate of the Company
	[     ] 
	 	 	 
	(e) 	
      a close business associate of a director, executive
      officer or control person of the Company or an affiliate of the
    Company
	[     ] 
	 	 	 
	(f) 	
      a founder of the Company or a spouse, parent,
      grandparent, brother, sister, child, close personal friend or close
      business associate of a founder of the Company
	[     ] 
	 	 	 
	(g) 	
      a parent, grandparent, brother, sister or child of the
      spouse of a founder of the Company
	[     ] 
	 	 	 
	(h) 	
      a company, partnership or other entity which a majority
      of the voting securities are beneficially owned by, or a majority of the
      directors are, persons or companies as described in paragraphs (a) to (g)
      above
	[     ] 
	 	 	 
	(i) 	
      purchasing the Units as principal with an aggregate value
      of more than CDN$150,000
	[     ] 
	 	 	 
	(j) 	
      an accredited investor
	[    
] 

	2. 	
      if the Subscriber has checked one or more of boxes b, c,
      d, e, f, g or h in section 1 above, the director(s), executive officer(s),
      control person(s) or founder(s) of the Company with whom the Subscriber
      has the relationship is:

	 	 
	 	 
 
	 	 
 
	 	 
 

(Instructions to Subscriber: fill in the name of each
director, executive officer, founder and control person which you have the
above-mentioned relationship with. If you have checked box h, also indicate
which of a to g describes the securityholders or directors which qualify you as
box h and provide the names of those individuals. Please attach a separate page
if necessary).

11

	3. 	
      If the Subscriber has ticked box j in section 1 above,
      the Subscriber acknowledges and agrees that the Company shall not consider
      the Subscriber’s request for the Units for acceptance unless the
      undersigned provides to the Company:

	 	 	 
		(i) 	
      the information required in sections 4 and 5;
  and

	 	 	 
		(ii) 	
      such other supporting documentation that the Company or
      its legal counsel may request to establish the Subscriber’s qualification
      as an Accredited Investor;

	 	 	 
	4. 	
      the Subscriber has such knowledge and experience in
      financial and business matters as to be capable of evaluating the merits
      and risks of the Transaction and the Subscriber is able to bear the
      economic risk of loss arising from such Transaction;

	 	 	 
	5. 	
      the Subscriber satisfies one or more of the categories of
      “accredited investor” (as that term is defined in NI 45-106) indicated
      below (please check the appropriate box):

	[     ] 	
      an individual who, either alone or with a spouse,
      beneficially owns, directly or indirectly, financial assets (as defined in
      NI 45-106) having an aggregate realizable value that, before taxes, but
      net of any related liabilities, exceeds CDN$1,000,000; 

	 	
      

	[     ] 	
      an individual whose net income before taxes exceeded
      CDN$200,000 in each of the two most recent calendar years or whose net
      income before taxes combined with that of a spouse exceeded CDN$300,000 in
      each of those years and who, in either case, reasonably expects to exceed
      that net income level in the current calendar year; 

	 	
      

	[     ] 	
      an individual who, either alone or with a spouse, has net
      assets of at least CDN$5,000,000; 

	 	
      

	[     ] 	
      an entity, other than an individual or investment fund,
      that has net assets of at least CDN$5,000,000 as shown on its most
      recently prepared financial statements; 

	 	
      

	[     ] 	
      an entity registered under the securities legislation of
      a jurisdiction of Canada as an advisor or dealer, other than a person
      registered solely as a limited market dealer under one or both of the
      Securities Act (B.C.) or any entity organized in a foreign
      jurisdiction that is analogous to any such person or entity; or 

	 	
      

	[     ] 	
      an entity in respect of which all of the owners of
      interests, direct, indirect or beneficial, except the voting securities
      required by law to be owned by directors, are persons or companies that
      are accredited investors. 

The Subscriber acknowledges and agrees that the Subscriber may
be required by the Company to provide such additional documentation as may be
reasonably required by the Company and its legal counsel in determining the
Subscriber’s eligibility to acquire the Units under relevant securities
legislation.

12

IN WITNESS WHEREOF, the undersigned has executed this Investor
Exemptions Questionnaire 

		    
      Date:_____________________, 2010 
	Signature 	 
	  	 
	  	 
	Hassan Salari 	 
	  	 
	Print Name	 
		 
	 	 
	 	 
	Title (if applicable) 	 

13

Schedule “C”

ACCREDITED INVESTOR QUESTIONNAIRE

The undersigned satisfies one or more of the categories of
"Accredited Investors", as defined by Regulation D promulgated under the “U.S.
Securities Act, as indicated below: (Please initial in the space provide those
categories, if any, of an "Accredited Investor" which the undersigned
satisfies.)

	[ ] 	Category 1 	
      An organization described in Section 501(c)(3) of the
      United States Internal Revenue Code, a corporation, a Massachusetts or
      similar business trust or partnership, not formed for the specific purpose
      of acquiring the Units, with total assets in excess of US $5,000,000.
    

	 	  	
    

	[ ] 	Category 2 	
      A natural person whose individual net worth, or joint net
      worth with that person's spouse, on the date of purchase exceeds US
      $1,000,000. 

	 	  	
    

	[ ] 	Category 3 	
      A natural person who had an individual income in excess
      of US $200,000 in each of the two most recent years or joint income with
      that person's spouse in excess of US $300,000 in each of those years and
      has a reasonable expectation of reaching the same income level in the
      current year. 

	 	  	
    

	[ ] 	Category 4 	
      A "bank" as defined under Section (3)(a)(2) of the 1933
      Act or savings and loan association or other institution as defined in
      Section 3(a)(5)(A) of the Securities Act acting in its individual or
      fiduciary capacity; a broker dealer registered pursuant to Section 15 of
      the Securities Exchange Act of 1934 (United States); an insurance
      company as defined in Section 2(13) of the 1933 Act; an investment company
      registered under the Investment Company Act of 1940 (United States)
      or a business development company as defined in Section 2(a)(48) of such
      Act; a Small Business Investment Company licensed by the U.S. Small
      Business Administration under Section 301(c) or (d) of the Small
      Business Investment Act of 1958 (United States); a plan with total
      assets in excess of $5,000,000 established and maintained by a state, a
      political subdivision thereof, or an agency or instrumentality of a state
      or a political subdivision thereof, for the benefit of its employees; an
      employee benefit plan within the meaning of the Employee Retirement
      Income Security Act of 1974 (United States) whose investment
      decisions are made by a plan fiduciary, as defined in Section 3(21) of
      such Act, which is either a bank, savings and loan association, insurance
      company or registered investment adviser, or if the employee benefit plan
      has total assets in excess of $5,000,000, or, if a self-directed plan,
      whose investment decisions are made solely by persons that are accredited
      investors. 

14

	[ ] 	Category 5 	
      A private business development company as defined in
      Section 202(a)(22) of the Investment Advisers Act of 1940 (United
      States). 

	 	  	
    

	[ ] 	Category 6 	
      A director or executive officer of the Company.

	 	  	
    

	[ ] 	Category 7 	
      A trust with total assets in excess of $5,000,000, not
      formed for the specific purpose of acquiring the Units, whose purchase is
      directed by a sophisticated person as described in Rule 506(b)(2)(ii)
      under the 1933 Act. 

	 	  	
    

	[ ] 	Category 8 	
      An entity in which all of the equity owners satisfy the
      requirements of one or more of the foregoing categories.

Note that the Subscriber claiming to
satisfy one of the above categories of Accredited Investor may be required to
supply the Company with a balance sheet, prior years' federal income tax returns
or other appropriate documentation to verify and substantiate the Subscriber's
status as an Accredited Investor.

If the Subscriber is an entity
which initialled Category 8 in reliance upon the Accredited Investor categories
above, state the name, address, total personal income from all sources for the
previous calendar year, and the net worth (exclusive of home, home furnishings
and personal automobiles) for each equity owner of the said entity: 

IN WITNESS WHEREOF, I have executed this Accredited Investor
Questionnaire.

	                                                                                                                                             	    
      Date: ____________________________, 2009 
	Signature 	  
	  	  
	  	  
	Hassan Salari 	  
	Print Name 	  
	  	  
		  
	Title (if applicable) 	  

15

	Schedule “D” 
 
	WARRANT CERTIFICATE 
 
	WARRANTS TO PURCHASE SHARES 
	OF COMMON STOCK OF NEUROKINE PHARMACEUTICALS INC.
  

	Certificate No. ____________	1,000,000 Warrants 

This Warrant Certificate certifies that Hassan Salari (the
“Subscriber”) is the owner of 1,000,000 Warrants (subject to adjustment as
provided herein), each of which represents the right to subscribe for and
purchase from Neurokine Pharmaceuticals Inc. (the “Company”), a share of the
Company’s the common stock, without par value, (the common stock, including any
stock into which it may be changed, reclassified or converted, is herein
referred to as the “common stock”) at the purchase price (the
“Exercise Price”) of US$0.05 per share on or before July 29, 2015.
This Warrant Certificate represents only Warrants issued pursuant to the
Agreement, between the Company and the Subscriber.

THESE WARRANTS AND THE SECURITIES
ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND ARE SUBJECT TO CERTAIN RESTRICTIONS, CONTAINED IN
PARAGRAPH 6 HEREOF, WITH RESPECT TO THEIR TRANSFER.

     The Warrants represented by this
Warrant Certificate are subject to the following provisions, terms and
conditions:

1. EXERCISE OF WARRANTS

Exercise of Warrants. The Warrants may be exercised by
the Subscriber, in whole or in part (but not as to a fractional share of common
stock), by: 

	 	(a) 	
      surrender of this Warrant Certificate at the principal
      office of the Company with the appropriate form attached hereto as Exhibit
      A duly exercised, at any time within the period beginning on the date of
      the execution of this Warrant Certificate and expiring five (5) years
      thereafter (the “Exercise Period”), and

	 	 	 
	 	(b) 	
      by payment to the Company by certified check or bank
      draft of the purchase price for such shares.

The Company agrees that the shares of common stock so purchased
shall be and are deemed to be issued to the Subscriber as the record owner of
such shares of common stock as of the close of business on the date on which the
Warrant Certificate shall have been surrendered and payment made for such shares
of common stock. Certificates representing the shares of common stock so
purchased shall be delivered to the Subscriber promptly and in no event later
than ten (10) days after the Warrants shall have been so exercised, and, unless
the Warrants have expired, a new Warrant Certificate representing the number of
Warrants represented by the surrendered Warrant Certificate, if any, that shall
not have been exercised shall also be delivered to the Subscriber within such
time.

2. CASHLESS EXERCISE

In lieu of exercising these Warrants for cash, the Subscriber
shall have the right to exercise these Warrants or any portion thereof (the
"Cashless Exercise Option") into shares of the Company’s common stock as
provided in this Section 2 at any time or from time to time during the period
specified in Section 1 of this Warrant Certificate by the surrender of this
Warrant Certificate to the Company with a duly executed and completed
Subscription Agreement marked to reflect cashless exercise. Upon exercise of the
Cashless Exercise Option with respect to a particular number of shares subject
to these Warrants and noted on the Subscription Agreement (the "Cashless Exercise Securities"), the Company shall deliver to
the Subscriber (without payment by the Subscriber of any Exercise Price or any
cash or other consideration) that number of shares of fully paid and
non-assessable shares of the Company’s common stock equal to the quotient
obtained by dividing (X) the value of this Warrant (or the specified portion
hereof) on the Cashless Exercise Date, which value shall be determined by
subtracting (A) the aggregate Exercise Price of the Cashless Exercise Securities
immediately prior to the exercise of the Cashless Exercise Option from (B) the
aggregate 5 trading day average of the closing price of the Company’s common
stock on the OTC Bulletin Board (the “Market Value”) of the Cashless Exercise
Securities issuable upon exercise of this Warrant (or the specified portion
hereof) on the Cashless Exercise notice date by (Y) Market Value of one share of
the Company’s common stock on the Cashless Exercise notice date.

16

Securities issuable upon exercise of this Warrant Certificate
(or the specified portion hereof) on the Cashless Exercise notice date, by (Y)
the Market Value of one share of the Company’s common stock on the Cashless
Exercise notice date.

Expressed as a formula as shown below, such net issuance
exercise shall be computed as follows:

X = B-A 
-----------
     Y

where:

		X 	= the number of shares of the Company’s common
      stock that may be issued to the Subscriber 
	 	  	  
		Y 	= the Market Value of one share of the
      Company’s common stock as of the Cashless Exercise notice date 
	 	  	  
		A 	= the aggregate Exercise Price (i.e. the
      product determined by multiplying the Cashless Exercise Securities by the
      Exercise Price per Security) 
	 	  	  
		B 	= the aggregate Market Value (i.e. the product
      determined by multiplying the Market Value by the Cashless Exercise
      Securities). 

3. ADJUSTMENTS

Adjustments. The Exercise Price and the number of shares
of common stock issuable upon exercise of each Warrant shall be subject to
adjustment from time to time as follows: 

Stock Dividends; Stock Splits;
Reverse Stock Splits; Reclassifications. In case the Company shall (i)
subdivide its outstanding shares of common stock, (ii) combine its outstanding
shares of common stock into a smaller number of shares of any class of common
stock or (iii) issue any shares of its capital stock in a reclassification of
the common stock (including any such reclassification in connection with a
merger, consolidation or other business combination in which the Company is the
continuing corporation) (any one of which actions is herein referred to as an
“Adjustment Event”), the number of shares of common stock purchasable
upon exercise of each of the Warrants immediately prior to the record date for
such Adjustment Event shall be adjusted so that the Subscriber shall thereafter
be entitled to receive the number of shares of common stock or other securities
of the Company (such other securities thereafter enjoying the rights of shares
of common stock under this Warrant Certificate) that such Subscriber would have
owned or have been entitled to receive after the happening of such Adjustment
Event, had such Warrants been exercised immediately prior to the happening of
such Adjustment Event or any record date with respect thereto. 

17

An adjustment made pursuant to this
Section 2A shall become effective immediately after the effective date of such
Adjustment Event retroactive to the record date, if any, for such Adjustment
Event.

Adjustment of Exercise Price.
Whenever the number of shares of common stock purchasable upon the exercise of
each of the Warrants is adjusted pursuant to Section 2A, the Exercise Price for
each share of common stock payable upon exercise of each of the Warrants shall
be adjusted by multiplying such Exercise Price immediately prior to such
adjustment by a fraction, the numerator of which shall be the number of shares
of common stock purchasable upon the exercise of each of the Warrants
immediately prior to such adjustment, and the denominator of which shall be the
number of shares of common stock so purchasable immediately thereafter.

Statement on Warrant Certificates. The form of this
Warrant Certificate need not be changed because of any change in the Exercise
Price or in the number of kind of shares purchasable upon the exercise of a
Warrant and any Warrant Exercise Price and the same number and kind of shares as
are stated in this Warrant Certificate. However, the Company may at the time in
its sole discretion make any change in the form of the Warrant Certificate that
it may deem appropriate and that does not affect the substance thereof and any
Warrant Certificate thereafter issued, whether in exchange or substitution for
any outstanding Warrant Certificate or otherwise, may be in the form so
changed.

4. RESERVATION AND AUTHORIZATION OF COMMON STOCK

The Company covenants and agrees 

	 	(a) 	
      that all shares of common stock which may be issued upon
      the exercise of the Warrants represented by this Warrant Certificate will,
      upon issuance, be validly issued, fully paid and non-assessable and free
      of all insurance or transfer taxes, liens and charges with respect to the
      issue thereof,

	 	 	 
	 	(b) 	
      that during the Exercise Period, the Company will at all
      times have authorized, and reserved for the purpose of issue or transfer
      upon exercise of the Warrants evidenced by this Warrant Certificate,
      sufficient shares of common stock to provide for the exercise of the
      Warrants represented by this Warrant Certificate, and

	 	 	 
	 	(c) 	
      that the Company will take all such action as may be
      necessary to ensure that the shares of common stock issuable upon the
      exercise of the Warrants may be so issued without violation of any
      applicable law or regulation, or any requirements of any domestic
      securities exchange upon which any capital stock of the Company may be
      listed, provided, however, that nothing contained herein shall impose upon
      the Company any obligation to register the warrants evidenced by this
      Warrant Certificate or such common stock under applicable securities laws
      except as provided in the Subscription Agreement.

In the event that any securities of the Company other than the
common stock are issuable upon exercise of the Warrants, the Company will take
or refrain from taking any action referred to in clauses (A) through (c) of this
Section 3 as though such clauses applied, mutatis mutandis to such other
securities then issuable upon the exercise of the Warrants.

18

5. NO VOTING RIGHTS

This Warrant Certificate shall not entitle the Subscriber
hereof to any voting rights or other rights as a stockholder of the Company.

6. TRANSFER OF WARRANTS OR COMMON STOCK

The Subscriber agrees to be bound by the provisions contained
in the Agreement with respect to the limitations, including limitations imposed
for Securities Act compliance, on the transfer of the Warrants and the shares of
common stock issuable upon exercise of the Warrants.

7. RESTRICTIONS

(a) No Registration. The
Subscriber acknowledges and understands that the Warrants have not been
registered under the U.S. Securities Act or any other securities laws, are not
qualified for resale in the U.S., and that the Warrants must be held
indefinitely unless subsequently registered under the U.S. Securities Act or an
exemption from such registration is available. The Company has agreed to
register the shares underlying the Warrants for resale in the United States.

(b) Restrictions on Transfer.
The Issuer shall refuse to register any transfer of the Warrants or the shares
of common stock not made in accordance with the provisions of Regulation S of
the U.S. Securities Act, pursuant to registration under the U.S. Securities Act
or pursuant to an available exemption from registration.

(c) Legend. The Subscriber
acknowledges and understands that the certificates representing the Warrants or
the shares of common stock will be stamped with the following legends (or
substantially equivalent language) restricting transfer in the following
manner:

If the Subscriber is a Canadian
resident:

“THE SECURITIES REPRESENTED HEREBY
HAVE BEEN OFFERED IN AN OFFSHORE TRANSACTION TO A PERSON WHO IS NOT A U.S.
PERSON (AS DEFINED HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”).

NONE OF THE SECURITIES REPRESENTED
HEREBY HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES
LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR
INDIRECTLY, IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT
IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE
SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED
STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE 1933
ACT.”

and 

19

“UNLESS PERMITTED UNDER SECURITIES
LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE
DATE THAT IS FOUR MONTHS AND A DAY AFTER THE LATER OF (i) THE PURCHASE OF THESE
SECURITIES AND (ii) THE DATE THE ISSUER BECAME A REPORTING ISSUER IN ANY
PROVINCE OR TERRITORY.”

If the Subscriber is a U.S.
resident:

“NONE OF THE SECURITIES REPRESENTED
HEREBY HAVE BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “1933 ACT”), OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO
REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED
STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE
PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE
CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED STATES” AND “U.S.
PERSON” ARE AS DEFINED BY REGULATION S UNDER THE 1933 ACT.”

and if the Shares are being sold
outside of the United States in accordance with Rule 904 of Regulation S, the
legend Regulations S legend may be removed by providing a declaration to the
Company’s registrar and transfer agent in such form as the Company may
prescribe, including an opinion of counsel that such sale complies with the
requirements of the U.S. Securities Act;

8. CLOSING OF BOOKS

The Company will at no time close its transfer books against
the transfer of any Warrants or of any shares of common stock or other
securities issuable upon the exercise of any Warrants in any manner which
interferes with the timely exercise of the Warrants.

9. WARRANTS EXCHANGEABLE, LOSS, THEFT

This Warrant Certificate is exchangeable, upon the surrender
hereof of any Subscriber at the office or agency of the Company referred to in
Section 1, for new Warrant, each such new Warrants to represent the right to
subscribe and purchase such number of shares of common stock as shall be
designated by said Subscriber hereof at the time of such surrender. Upon receipt
of evidence satisfactory to the Company of the loss, theft, destruction or
mutilation, or upon surrender or cancellation of this Warrant Certificate, the
Company will issue to the Subscriber a new Warrant Certificate of like tenor, in
lieu of this Warrant Certificate, representing the right to subscribe for and
purchase the number of shares of common stock which may be subscribed for and
purchased hereunder.

10. MERGERS, CONSOLIDATIONS, ETC.

If the Company shall merge or consolidate with another
corporation, the Subscriber thereafter has the right, upon exercise hereof and
payment of the Exercise Price, to receive solely the kind and amount of shares
of stock, other securities, property or cash or any combination thereof
receivable by a Subscriber of the number of shares of common stock for which
this Warrants might have been exercised immediately prior to such merger or
consolidation (assuming, if applicable, that the holder of such common stock
failed to exercise its rights of election, if any, as to the kind or amount of shares of stock, other securities,
property or cash or combination thereof receivable upon such merger or
consolidation).

20

In case of any reclassification or change of the shares of
common stock issuable upon exercise of these Warrants (other than elimination or
par value, a change in par value, or from par value to no par value, or as the
result of a subdivision or combination of shares (which is provided for
elsewhere herein), but including any reclassification of the shares of Common
stock into two or more classes or series of shares) or in case of any merger or
consolidation of another corporation into the Company in which the Company is
the surviving corporation and in which there is a reclassification or change of
the shares of common stock (other than a change in par value, or from par value
to no par value, or as a result of a subdivision or combination (which is
provided for elsewhere herein), but including any reclassification of the shares
of common stock underlying the Warrants, shall thereafter have the right, upon
exercise hereof and payment of the Exercise Price, to receive solely the kind
and amount of shares of stock (including, if applicable, common stock), other
securities, property or cash or any combination thereof receivable upon such
reclassification, change, merger or consolidation by a holder of the number of
shares of common stock for which these Warrants might have been exercised
immediately prior to such reclassification, change, merger or consolidation
(assuming, if applicable, that the holder of such common stock failed to
exercise its rights of election, if any, as to the kind or amount of shares of
stock, other securities, property or cash or combination thereof receivable upon
such reclassification, change, merger or consolidation).

11. RIGHTS AND OBLIGATIONS SURVIVE EXERCISE OF WARRANTS

The rights and obligations of the Company, of the Subscriber,
and of the holders of shares of common stock or other securities issued upon
exercise of the Warrants, contained in Sections 5 and 7 of this Warrant
Certificate shall survive the exercise of the Warrants.

	 	NEUROKINE PHARMACEUTICALS INC. 

  
	 	Ahmad Doroudian, President and CEO
  

21Neurokine Pharmaceuticals Inc.: Exhibit 10.2 - Filed by newsfilecorp.com

	Neurokine Pharmaceuticals Inc. 
	1275 West 6th Avenue,
      Vancouver, BC, Canada V6H 1A6 
	Private Placement Subscription Agreement 
	for Non U.S. Residents 

	 	 	 	 
	Name of
      Purchaser 	Ahmad
      Doroudian 	  	(the
      “Purchaser”) 
	 	 	 	 
	Tax ID or SIN 	 	  	     
	 	 	 	 
	Address 	4172
      Doncaster Way 	  	     
	 	 	 	 
	City 	Vancouver 	  	     
	 	 	 	 
	Province 	British Columbia 	  	     
	 	 	 	 
	Country 	Canada    	  	     
	 	 	 	 
	Postal Code 	V6S
      1V9 	  	     
	 	 	 	 
	Telephone 	(604)
      221-0595 	  	     
	 	 	 	 
	Date 	July
      29, 2010 	  	     
	 	 	 	 
	Payment
      Method 	 	  	     
	  	 	  	  
	Number of Units
      Purchased 	500,000 	x US$0.005 = 	$2,500 
	Each Unit consists
      of one share of our common
      stock and one common stock purchase warrant 	(the “Units”) 	  	Subscription Price 
	  	 	  	  
	 	 	 
	Signature of
      Purchaser 	 	 

The Purchaser subscribes for and agrees to purchase from
Neurokine Pharmaceutical Inc., a British Columbia (the "Company"), units with
each unit (the “Unit”) consisting of one share of our common stock and one
warrant, to purchase a a share of common stock of the Company at an exercise
price of US$0.005 per share and in accordance other terms as set out in Schedule
“D” hereto , to be recorded in the name of the Purchaser at the address set out
above, all on the terms and subject to the conditions set forth in Schedule “A”
attached hereto.

These securities have not been registered under the Securities
Act of 1933 (the “U.S. Securities Act”) and may not be offered or sold in the
United States or to U.S. persons (other than distributors) unless the securities
are registered under the Act, or an exemption from the registration requirements
of the Act is available. Hedging transactions involving these securities may not
be conducted unless in compliance with the U.S. Securities Act.

The foregoing Subscription is accepted for and on behalf of
Neurokine Pharmaceuticals Inc.:

	By: 		Date: 	July                      
       , 2010 
	 	Ahmad Doroudian, President 	  	 

1

Schedule “A”

     In consideration of the covenants
and agreements herein, and the payment of one dollar made by each party to the
other, the receipt and sufficiency of which is acknowledged by each party, the
parties agree as follows:

Delivery of Documents and Funds

		
      The Subscriber hereby delivers to the Company:

	 	 
	1. 	
      a completed and executed copy of this
Agreement;

	 	 
	2. 	
      for all Subscribers: a completed and executed Investor
      Exemptions Questionnaire attached as Schedule “B” and in the case of a
      subscription for the Units by Subscriber acting as trustee or agent for a
      principal, the Subscriber shall provide the Company an Accredited Investor
      Questionnaire in the form set forth in Schedule “B” for each trust,
      beneficial owner and/or principal for which the Subscriber is acting as
      trustee or agent;

	 	 
	3. 	
      if the Subscriber is a U.S. Person, additionally: a
      completed and executed Accredited Investor Questionnaire attached as
      Schedule “C” and in the case of a subscription for the Units by Subscriber
      acting as trustee or agent for a principal, the Subscriber shall provide
      the Company an Accredited Investor Questionnaire in the form set forth in
      Schedule “C” for each trust, beneficial owner and/or principal for which
      the Subscriber is acting as trustee or agent; and

	 	 
	4. 	
      a certified check or bank draft for the Funds made
      payable to “Neurokine Pharmaceuticals Inc.”

Closing

     The closing of the transactions
contemplated by this Agreement (the “Closing”) will take place as subscriptions
are received by the Company.

     At Closing, the Company will
deliver to the Subscriber the certificates representing the Units and an
agreement representing the Warrants purchased by the Subscriber registered in
the name of the Subscriber or as directed on the cover page of this Agreement.

Subscriber’s Representations, Warranties, Covenants,
Acknowledgements and Agreements

	1. 	
      The Subscriber represents and warrants to the Company,
      and acknowledges that the Company is relying on these representations and
      warranties to, among other things, ensure that it is complying with all of
      the applicable securities legislation, that:

	 	 	 	 
		(a) 	
      the Subscriber is purchasing as principal and is either
      :

	 	 	 	 
			(i) 	
      not a U.S. person and is not acquiring the Units for the
      account or benefit of any U.S. person; OR

	 	 	 	 
			(ii) 	
      a U.S. person who is purchasing the Units in a
      transaction that does not require registration under the U.S. Securities
      Act.

	 	 	 	 
		(b) 	
      if the Subscriber is a resident of an “International
      Jurisdiction” (which means a jurisdiction other than British Columbia),
      then:

2

	 	(i) 	
      the Subscriber is knowledgeable of, or has been
      independently advised as to, the applicable securities legislation of the
      International Jurisdiction which would apply to this subscription, if
      there are any;

	 	 	 
	 	(ii) 	
      the Subscriber is purchasing the Units pursuant to
      exemptions under the securities legislation of that International
      Jurisdiction or, if such is not applicable, the Subscriber is permitted to
      purchase the Units under the applicable securities legislation of the
      International Jurisdiction without the need to rely on exemptions;
    and

	 	 	 
	 	(iii) 	
      the applicable securities legislation does not require
      the Company to make any filings or seek any approvals of any kind
      whatsoever from any regulatory authority of any kind whatsoever in the
      International Jurisdiction; and

the Subscriber will, if requested by
the Company, deliver to the Company a certificate or opinion of local counsel
from the International Jurisdiction which will confirm the matters referred to
in subparagraphs (ii) and (iii) above to the satisfaction of the Company, acting
reasonably;

		(c) 	
      if the Subscriber is a U.S. Person (as defined under
      Regulation S promulgated under the United States Securities Act of 1933,
      as amended (the “U.S. Securities Act”), which definition includes an
      individual resident in the United States and an estate or trust of which
      any executor or administrator or trustee, respectively, is a U. S.
      Person), then:

	 	 	 	 
			
      (i) 
	the Subscriber understands that the Units have not been
      and will not be registered under the U.S. Securities Act or any applicable
      state securities laws, and that the sale contemplated hereby is being made
      in reliance on an exemption from registration pursuant to Section 4(6) of
      the U.S. Securities Act to accredited investors (as that term is defined
      in Rule 501(a) of Regulation D under the U.S. Securities Act, (an
      “Accredited Investor”)); AND
	 	 	 	 
			
      (ii) 
	the Subscriber agrees that if it decides to offer, sell
      or otherwise transfer any of the Units, it will not offer, sell or
      otherwise transfer any of such Units directly or indirectly,
  unless:

	 	(A) 	
      the Company’s securities are publicly traded on a
      national securities exchange, the Nasdaq Stock Market or the OTC Bulletin
      Board; or

	 	 	 
	 	(B) 	
      the Company consents, in its sole discretion, in writing
      to such transfer and the transfer is made outside the United States in a
      transaction meeting the requirements of Rule 904 of Regulation S under the
      U.S. Securities Act (“Regulation S”) (or such successor rule or regulation
      then in effect), if applicable, and in compliance with applicable state
      securities laws and it has prior to such sale furnished to the Company an
      opinion of counsel, in a form reasonably satisfactory to the Company
      regarding compliance with Rule 904 and any applicable state securities
      laws; or the transfer is made pursuant to an exemption from the
      registration requirements under the U.S. Securities Act provided by Rule
      144A or 144 thereunder, if available, and in accordance with any
      applicable state securities laws and it has prior to such sale furnished
      to the Company an opinion of counsel, in a form reasonably satisfactory to the Company
regarding compliance with Rule 144A or 144, as applicable, and any applicable
state securities laws; AND

3

	 	(iii) 	
      the Subscriber understands and acknowledges that upon the
      issuance thereof, and until such time as the same is no longer required
      under applicable requirements of the U.S. Securities Act or applicable
      state securities laws, the certificates representing the Units shall bear,
      the following legends:

	 	 	 
	 		
      If the Subscriber is a Canadian resident:

	 	 	 
	 		
      “THE SECURITIES REPRESENTED HEREBY HAVE BEEN OFFERED IN
      AN OFFSHORE TRANSACTION TO A PERSON WHO IS NOT A U.S. PERSON (AS DEFINED
      HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF
      1933, AS AMENDED (THE “1933 ACT”).

	 	 	 
	 		
      NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN
      REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND,
      UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY,
      IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN
      ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT,
      PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR
      PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN
      ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING
      TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN
      COMPLIANCE WITH THE 1933 ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS
      DEFINED BY REGULATION S UNDER THE 1933 ACT.”

	 	 	 
	 		
      and

	 	 	 
	 		
      “UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE
      HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT
      IS FOUR MONTHS AND A DAY AFTER THE LATER OF (i) THE PURCHASE OF THESE
      SECURITIES AND (ii) THE DATE THE ISSUER BECAME A REPORTING ISSUER IN ANY
      PROVINCE OR TERRITORY.”

	 	 	 
	 		
      If the Subscriber is a U.S. resident:

	 	 	 
	 		
      “NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN
      REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE
      “1933 ACT”), OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED,
      MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES
      (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE
      PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE
      REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE
      EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS
      INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH
      THE 1933 ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY
      REGULATION S UNDER THE 1933 ACT.”

4

and if the Units are being sold
outside of the United States in accordance with Rule 904 of Regulation S, the
legend Regulations S legend may be removed by providing a declaration to the
Company’s registrar and transfer agent in such form as the Company may
prescribe, including an opinion of counsel that such sale complies with the
requirements of the U.S. Securities Act;

		(d) 	
      the Subscriber acknowledges that:

	 	 	 	 
			(i) 	
      no securities commission or similar regulatory authority
      has reviewed or passed on the merits of the Units;

	 	 	 	 
			(ii) 	
      there is no government or other insurance covering the
      Units;

	 	 	 	 
			(iii) 	
      there are risks associated with the purchase of the
      Units;

	 	 	 	 
			(iv) 	
      there are restrictions on the Subscriber’s ability to
      resell the Units and it is the responsibility of the Subscriber to find
      out what those restrictions are and to comply with them before selling the
      Units;

	 	 	 	 
			(v) 	
      the Subscriber is restricted from using certain of the
      civil remedies available under the applicable securities
    legislation;

	 	 	 	 
			(vi) 	
      the Subscriber may not receive information that might
      otherwise be required to be provided to the Subscriber under the
      applicable securities legislation if the exemptions were not being
      used;

	 	 	 	 
			(vii) 	
      the Company is relieved from certain obligations that
      would otherwise apply under the applicable securities legislation if the
      exemptions were not being used; and

	 	 	 	 
			(viii) 	
      the Company is relying on exemptions in applicable
      securities laws from the requirements to provide the Subscriber with a
      prospectus and to sell the Units through a person registered to sell
      securities and the Subscriber understands that the exemptions release the
      Company from the requirements to provide the Subscriber with a prospectus
      and to sell Stock through a person registered to sell securities under the
      Securities Act (British Columbia) and, as a consequence of
      acquiring Stock pursuant to those exemptions, certain protections, rights
      and remedies provided by the Securities Act (British Columbia),
      including statutory rights of rescission or damages, will not be available
      to the Subscriber;

	 	 	 	 
	 	
      (e) 
	the Subscriber is subscribing for the Units as principal
      for its own account and not for the benefit of any other person (within
      the meaning of applicable securities laws) and not with a view to resale
      or distribution of all or any of the Units or, if it is not subscribing as
      principal, it acknowledges that the Company may be required by law to
      disclose to certain regulatory authorities the identity of each beneficial
    Subscriber for the Units for whom it is acting;

	 	 	 	 
	 	(f)      	in the case of a subscription for the Units by the
      Subscriber acting as trustee or agent (including, for greater certainty, a
      portfolio manager or comparable adviser) for another person or entity, the
      Subscriber is duly authorized to execute and deliver this Subscription
      Agreement and all other necessary documentation in connection with such
      subscription on behalf of each such beneficial person, each of whom is
      subscribing for its own account, not for the benefit of any other person
      and not with a view to the resale or distribution of the Units and
      this Agreement has been duly authorized, executed and delivered by or on
      behalf of and constitutes a legal, valid and binding agreement of, such
      principal, and the Subscriber acknowledges that the Company may be
      required by law to disclose the identity of each beneficial Subscriber for
  whom the Subscriber is acting;

5

	 	(g) 	
      the offer and sale of these Units was not accomplished by
      an advertisement or other general solicitation (and the Subscriber has not
      attended any seminar or meeting whose attendees have been invited by
      general solicitation or general advertisement) and the Subscriber was not
      induced to purchase the Units as a result of any advertisement or general
      solicitation made by the Company; and

	 	 	 
	 	(h) 	
      if the Subscriber is a corporation, the Subscriber is a
      valid and subsisting corporation and was not organized for the purpose of
      acquiring the Units, has the necessary corporate capacity and authority to
      execute and deliver this Agreement and to observe and perform its
      covenants and obligations hereunder and has taken all necessary corporate
      action in respect thereof, or, if the Subscriber is an individual, a
      partnership, syndicate, trust or other form of unincorporated
      organization, the Subscriber has the necessary legal capacity and
      authority to execute and deliver this Agreement and to observe and perform
      its covenants and obligations hereunder and has obtained all necessary
      approvals in respect thereof, and, in either case, upon the Company
      executing and delivering this Agreement, this Agreement will constitute a
      legal, valid and binding contract of the Subscriber enforceable against
      the Subscriber in accordance with its terms and neither the agreement
      resulting from such acceptance nor the completion of the transactions
      contemplated hereby conflicts with, or will conflict with, or results, or
      will result, in a breach or violation of any law applicable to the
      Subscriber, any constating documents of the Subscriber or any agreement to
      which the Subscriber is a party or by which the Subscriber is
  bound;

	2. 	
      this subscription is given for valuable consideration and
      may not be withdrawn or revoked by the Subscriber;

	 	 
	3. 	
      the Company may for any reason, at any time before
      acceptance of this Agreement, terminate the offering of Units and, upon
      termination, the Company will return the Funds to the Subscriber without
      interest or deduction;

	 	 
	4. 	
      the Units will be subject to the following resale or
      transfer restrictions:

	 	(a) 	
      the Units will be subject to resale restrictions under
      applicable securities legislation including resale restrictions under the
      Securities Act (British Columbia) which include a hold period of at
      least four months;

	 	 	 
	 	(b) 	
      the Subscriber will not be able to resell, assign or
      otherwise dispose of the Units unless they are subsequently distributed
      under a prospectus, registration statement or in compliance with all
      applicable resale restrictions;

	 	 	 
	 	(c) 	
      the Company may be required to legend the certificates
      representing the Units regarding these and any other restrictions on
      resale; and

	 	 	 
	 	(d) 	
      while the Company has agreed use its commercially
      reasonably efforts to include the Units in a registration statement
      covering the resale of same pursuant to “piggy-back” registration rights,
      the Company is under no obligation to file a registration statement, or
      register the resale of the Units under a prospectus or registration
      statement, or assist the Subscriber in complying with any
  exemption from the prospectus or registration
statement requirements or resale restrictions set out under applicable
securities legislation; provided, however, that in connection with any
underwritten public offering by the Company, during the period of duration (not
to exceed 180 days) specified by the Company and an underwriter of common stock
of the Company following the effective date of a registration statement of the
Company with respect to such offering, the Subscriber will not, to the extent
requested by the Company and such underwriter, directly or indirectly sell,
offer to sell, contract to sell (including, without limitation, any short sale),
grant any option to purchase, pledge, or otherwise transfer or dispose of (other
than to donees who agree to be similarly bound) any of the Units of the Company
held by the Subscriber at any time during such period except common stock
included in such registration. If requested by such underwriter, the Subscriber
agrees to execute a lock-up agreement in such form as the underwriter may
reasonably propose.

6

	5. 	
      the Subscriber will not resell, assign or otherwise
      dispose of the Units other than in accordance with all applicable
      securities legislation and the requirements of any exchange or
      over-the-counter market upon which any securities of the Company are then
      listed;

	 	 
	6. 	
      the Subscriber’s investment in the Units is speculative
      and involves a high degree of risk, substantial financing for the Company
      may be required in the future, and there is no assurance that any such
      additional financing can be obtained;

	 	 
	7. 	
      the Subscriber is able to bear the economic risks of an
      investment in the Units, including, without limiting the generality of the
      foregoing, the risk of losing part or all of the Funds, and the inability
      to sell, convert, exchange or transfer the Units at a price which would
      enable the Subscriber to recoup his, her or its investment in the
      Units;

	 	 
	8. 	
      other than any persons to whom the Company has agreed to
      pay a brokerage or finder’s fee, there is no person acting or purporting
      to act in connection with the transactions contemplated herein who is
      entitled to any brokerage or finder’s fee. If any person establishes a
      claim that any fee or other compensation is payable in connection with
      this subscription for the Units, the Subscriber covenants to indemnify and
      hold harmless the Company with respect thereto and with respect to all
      costs reasonably incurred in the defence thereof;

	 	 
	9. 	
      the Subscriber, and each beneficial person for whom it is
      contracting hereunder, have been advised to consult their own legal
      advisors with respect to trading in the Units and with respect to the
      resale restrictions imposed by the securities laws of the state in which
      the Subscriber resides, the U.S. Securities Act and the rules and
      regulations thereunder, and any other applicable securities laws, and
      acknowledges that no representation has been made respecting the
      applicable hold periods or other resale restrictions applicable to such
      securities which restrict the ability of the Subscriber (or others for
      whom it is contracting hereunder) to resell such securities, that the
      Subscriber (or others for whom it is contracting hereunder) is solely
      responsible to find out what these restrictions are and the Subscriber is
      solely responsible (and the Company is not in any way responsible) for
      compliance with applicable resale restrictions and the Subscriber is aware
      that it (or beneficial persons for whom it is contracting hereunder) may
      not be able to resell such securities except in accordance with limited
      exemptions under the securities laws (including the U.S. Securities Act)
      and other applicable securities laws;

	 	 
	10. 	
      the Subscriber will execute, deliver, file and otherwise
      assist the Company in filing, any report, undertaking or document with
      respect to the purchase, sale, conversion or exchange of the Units as
      required by counsel for the Company;

7

	11. 	
      the Subscriber hereby authorizes the Company to correct
      any minor errors in, or complete any minor information missing from, any
      document which has been executed by the Subscriber and delivered to the
      Company with respect to this Subscription;

	 	 
	12. 	
      if, for any reason, the offering of Units is terminated
      or the Subscriber’s subscription is rejected, the Subscriber will have no
      claims against the Company, its directors and officers, shareholders,
      agents, advisors, and affiliates and shall have no interest in the Company
      or in any property or assets of the Company;

	 	 
	13. 	
      Subscriber acknowledges that there are risks associated
      with the purchase of and investment in the Units and the Subscriber, and
      each beneficial person for whom it is contracting hereunder, is
      knowledgeable, sophisticated and experienced in business and financial
      matters and is capable of evaluating the merits and risks of an investment
      in the Units, fully understands the restrictions on resale of the Units
      and is able to bear the economic risk of an investment in the
  Units;

	 	 
	14. 	
      the Subscriber is familiar with the aims and objectives
      of the Company and the proposed use of the proceeds received by the
      Company from the sale of the Units and is aware of the risk and other
      characteristics of an investment in the Units;

	 	 
	15. 	
      in evaluating the merits and risks of an investment in
      the Units, the Subscriber has relied solely upon the advice of his, her or
      its legal, tax and investment advisors and not any oral or written
      statement made by, or on behalf of, the Company or its advisors;

	 	 
	16. 	
      THE SUBSCRIBER IS RESPONSIBLE FOR OBTAINING HIS, HER OR
      ITS OWN LEGAL, INVESTMENT AND TAX ADVICE;

	 	 
	17. 	
      the Company may pay a commission or fee in respect of the
      sale of the Units;

	 	 
	18. 	
      the Subscriber and each beneficial person for whom it is
      acting is a resident in the jurisdiction set out on the face page of this
      Agreement. Such address was not created and is not used solely for the
      purpose of acquiring the Units and the Subscriber and any beneficial
      person was solicited to purchase in such jurisdiction and is acquiring the
      Units for its own account or for the account of another Accredited
      Investor (as defined in Rule 501(a) of Regulation D under the U.S.
      Securities Act) over which the Subscriber exercises sole investment
      discretion, and as to which the Subscriber has the authority to make the
      statements set forth in this Agreement, in each case not with a view to,
      or for offer or sale in connection with, any resale, distribution or other
      disposition of the Units in any transaction that would be in violation of
      the U.S. Securities Act or applicable state securities laws; and

	 	 
	19. 	
      The Subscriber, if an individual, is at least 18 years of
      age. If Subscriber is an association or entity, each individual member of
      the association or entity is at least 18 years of age. If Subscriber is
      acquiring the Units for the account of another person, such person, if an
      individual is at least 18 years of age, or if such person is an
      association or entity, each individual member of the association or entity
      is over 18 years of age.

8

Reliance Upon Representations, Warranties, Covenants,
Acknowledgements and Agreements

     The Subscriber acknowledges that
the representations, warranties, covenants, acknowledgements and agreements
contained in this Agreement are made with the intent that they may be relied
upon by the Company, and the Subscriber hereby agrees to indemnify the Company,
its officers, directors, employees and agents against all losses, claims, costs,
expenses and damages or liabilities which they may suffer or incur caused or
arising from their reliance thereon. The Subscriber covenants that the foregoing
representations, warranties, covenants, acknowledgements and agreements will be
true at the time of execution of this Agreement and at the date of issuance of
the Units and agrees that they shall survive the purchase by the Subscriber of
the Units.

Representations and Warranties of the Company

The Company represents and warrants
that:

	 	(a) 	
      the Company is a valid and subsisting corporation duly
      incorporated and in good standing under the laws of the jurisdiction in
      which it is incorporated;

	 	 	 
	 	(b) 	
      the Company is duly registered and licensed to carry on
      business in the jurisdictions in which it carries on business or owns
      property where required under the laws of those jurisdictions;

	 	 	 
	 	(c) 	
      the Company will reserve or set aside sufficient shares
      in its treasury to issue the Shares and any shares of common stock
      resulting from exercising the Warrants;

	 	 	 
	 	(d) 	
      the issue and sale of the Shares by the Company does not
      and will not conflict with, and does not and will not result in a breach
      of, any of the terms of the Company’s incorporating documents or any
      agreement or instrument to which the Company is a party; and

	 	 	 
	 	(e) 	
      this Agreement has been or will be by the Closing, duly
      authorized by all necessary corporate action on the part of the Company,
      and the Company has full corporate power and authority to undertake the
      offering.

Indemnity

     The Subscriber agrees to
indemnify and hold harmless the Company and its directors, officers, employees,
agents, advisers and shareholders from and against any and all loss, liability,
claim, damage and expense whatsoever including, but not limited to, any and all
fees, costs and expenses whatsoever reasonably incurred in investigating,
preparing or defending against any litigation, administrative proceeding or
investigation commenced or threatened or any claim whatsoever arising out of or
based upon any representation or warranty of the Subscriber contained herein or
in any document furnished by the Subscriber to the Company in connection
herewith being untrue in any material respect or any breach or failure by the
Subscriber to comply with any covenant or agreement made by the Subscriber
herein or in any document furnished by the Subscriber to the Company in
connection herewith.

9

Offering

     This offering of securities forms
part of a larger offering of similar securities being made by the Company. The
offering is not subject to any minimum subscription level and the Subscriber
acknowledges that he, she or it may be the only subscriber to the offering.

Costs

     The Subscriber acknowledges and
agrees that all costs and expenses incurred by the Subscriber, including any
fees and disbursements of any advisor retained by the Subscriber relating to the
purchase of the Units, shall be borne by the Subscriber.

Survival

     The representations, warranties,
covenants, acknowledgements and agreements contained in this Agreement shall
survive the Closing and will continue in full force and effect and be binding
upon the Subscriber notwithstanding any subsequent disposition by the Subscriber
of the Units.

Enurement

     This Agreement will enure to the
benefit of and be binding upon the Subscriber and the Company and their
respective heirs, administrators, representatives, successors and permitted
assigns.

Assignment

This Agreement is not transferable or assignable.

Registration

     The Company shall make all
reasonable efforts to have the Units registered with the Securities and Exchange
Commission within 60 days of the closing of this Agreement. 

Counterparts

     This Agreement may be executed in
as many counterparts as may be necessary and by facsimile, each of such
counterparts so executed will be deemed to be an original and such counterparts
together will constitute one and the same instrument.

10

Schedule “B”

INVESTOR EXEMPTIONS QUESTIONNAIRE

The purpose of this Questionnaire is to assure the Company that
the Subscriber will meet certain requirements for the registration and
prospectus exemptions provided for under National Instrument 45-106 (“NI
45-106”) in respect to the issuance of the Units pursuant to the Agreement. The
Company will rely on the information contained in this Questionnaire for the
purposes of such determination.

The undersigned Subscriber covenants, represents and warrants
to the Company that:

	1. 	they are (check one or more of the following
      boxes): 

	(a) 	
      a director, executive officer, employee or control person
      of the Company or an affiliate of the Company
	 [     ] 
	 	 	 
	(b) 	
      a spouse, parent, grandparent, brother, sister or child
      of a director, executive officer or control person of the Company or an
      affiliate of the Company
	 [     ] 
	 	 	 
	(c) 	
      a parent, grandparent, brother, sister or child of the
      spouse of a director, executive officer or control person of the Company
      or an affiliate of the Company
	 [     ] 
	 	 	 
	(d) 	
      a close personal friend of a director, executive officer
      or control person of the Company or an affiliate of the Company
	 [     ] 
	 	 	 
	(e) 	
      a close business associate of a director, executive
      officer or control person of the Company or an affiliate of the
    Company
	 [     ] 
	 	 	 
	(f) 	
      a founder of the Company or a spouse, parent,
      grandparent, brother, sister, child, close personal friend or close
      business associate of a founder of the Company
	 [     ] 
	 	 	 
	(g) 	
      a parent, grandparent, brother, sister or child of the
      spouse of a founder of the Company
	 [     ] 
	 	 	 
	(h) 	
      a company, partnership or other entity which a majority
      of the voting securities are beneficially owned by, or a majority of the
      directors are, persons or companies as described in paragraphs (a) to (g)
      above
	 [     ] 
	 	 	 
	(i) 	
      purchasing the Units as principal with an aggregate value
      of more than CDN$150,000
	 [     ] 
	 	 	 
	(j) 	
      an accredited investor
	 [     ]
  

	2. 	
      if the Subscriber has checked one or more of boxes b, c,
      d, e, f, g or h in section 1 above, the director(s), executive officer(s),
      control person(s) or founder(s) of the Company with whom the Subscriber
      has the relationship is:

	 	 
	 	 
 
	 	 
 
	 	 
 

(Instructions to Subscriber: fill in the name of each
director, executive officer, founder and control person which you have the
above-mentioned relationship with. If you have checked box h, also indicate
which of a to g describes the securityholders or directors which qualify you as
box h and provide the names of those individuals. Please attach a separate page
if necessary).

11

	3. 	
      If the Subscriber has ticked box j in section 1 above,
      the Subscriber acknowledges and agrees that the Company shall not consider
      the Subscriber’s request for the Units for acceptance unless the
      undersigned provides to the Company:

	 	 	 
		(i) 	
      the information required in sections 4 and 5;
  and

	 	 	 
		(ii) 	
      such other supporting documentation that the Company or
      its legal counsel may request to establish the Subscriber’s qualification
      as an Accredited Investor;

	 	 	 
	4. 	
      the Subscriber has such knowledge and experience in
      financial and business matters as to be capable of evaluating the merits
      and risks of the Transaction and the Subscriber is able to bear the
      economic risk of loss arising from such Transaction;

	 	 	 
	5. 	
      the Subscriber satisfies one or more of the categories of
      “accredited investor” (as that term is defined in NI 45-106) indicated
      below (please check the appropriate box):

	[ ] 	an individual who, either alone or with a
      spouse, beneficially owns, directly or indirectly, financial assets (as
      defined in NI 45-106) having an aggregate realizable value that, before
      taxes, but net of any related liabilities, exceeds CDN$1,000,000; 
	 	  
	[ ] 	an individual whose net income before taxes
      exceeded CDN$200,000 in each of the two most recent calendar years or
      whose net income before taxes combined with that of a spouse exceeded
      CDN$300,000 in each of those years and who, in either case, reasonably
      expects to exceed that net income level in the current calendar year;
  
	 	  
	[ ] 	an individual who, either alone or with a
      spouse, has net assets of at least CDN$5,000,000; 
	 	  
	[ ] 	an entity, other than an individual or
      investment fund, that has net assets of at least CDN$5,000,000 as shown on
      its most recently prepared financial statements; 
	 	  
	[ ] 	an entity registered under the securities
      legislation of a jurisdiction of Canada as an advisor or dealer, other
      than a person registered solely as a limited market dealer under one or
      both of the Securities Act (B.C.) or any entity organized in a
      foreign jurisdiction that is analogous to any such person or entity; or
  
	 	  
	[ ] 	an entity in respect of which all of the owners
      of interests, direct, indirect or beneficial, except the voting securities
      required by law to be owned by directors, are persons or companies that
      are accredited investors. 

The Subscriber acknowledges and agrees that the Subscriber may
be required by the Company to provide such additional documentation as may be
reasonably required by the Company and its legal counsel in determining the
Subscriber’s eligibility to acquire the Units under relevant securities
legislation.

12

IN WITNESS WHEREOF, the undersigned has executed this Investor
Exemptions Questionnaire 

		 Date:_____________________,
      2010 
	Signature 	 
	  	 
	  	 
	Ahmad Doroudian
	 
	Print Name 	 
	  	 
	  	 
	President, CEO and
      Director 	 
	Title (if applicable) 	 

13

Schedule “C”

ACCREDITED INVESTOR QUESTIONNAIRE

The undersigned satisfies one or more of the categories of
"Accredited Investors", as defined by Regulation D promulgated under the “U.S.
Securities Act, as indicated below: (Please initial in the space provide those
categories, if any, of an "Accredited Investor" which the undersigned
satisfies.)

	[ ] 	Category 1 	
      An organization described in Section 501(c)(3) of the
      United States Internal Revenue Code, a corporation, a Massachusetts or
      similar business trust or partnership, not formed for the specific purpose
      of acquiring the Units, with total assets in excess of US $5,000,000.
    

	 	  	
      

	[ ] 	Category 2 	
      A natural person whose individual net worth, or joint net
      worth with that person's spouse, on the date of purchase exceeds US
      $1,000,000. 

	 	  	
      

	[ ] 	Category 3 	
      A natural person who had an individual income in excess
      of US $200,000 in each of the two most recent years or joint income with
      that person's spouse in excess of US $300,000 in each of those years and
      has a reasonable expectation of reaching the same income level in the
      current year. 

	 	  	
      

	[ ] 	Category 4 	
      A "bank" as defined under Section (3)(a)(2) of the 1933
      Act or savings and loan association or other institution as defined in
      Section 3(a)(5)(A) of the Securities Act acting in its individual or
      fiduciary capacity; a broker dealer registered pursuant to Section 15 of
      the Securities Exchange Act of 1934 (United States); an insurance
      company as defined in Section 2(13) of the 1933 Act; an investment company
      registered under the Investment Company Act of 1940 (United States)
      or a business development company as defined in Section 2(a)(48) of such
      Act; a Small Business Investment Company licensed by the U.S. Small
      Business Administration under Section 301(c) or (d) of the Small
      Business Investment Act of 1958 (United States); a plan with total
      assets in excess of $5,000,000 established and maintained by a state, a
      political subdivision thereof, or an agency or instrumentality of a state
      or a political subdivision thereof, for the benefit of its employees; an
      employee benefit plan within the meaning of the Employee Retirement
      Income Security Act of 1974 (United States) whose investment
      decisions are made by a plan fiduciary, as defined in Section 3(21) of
      such Act, which is either a bank, savings and loan association, insurance
      company or registered investment adviser, or if the employee benefit plan
      has total assets in excess of $5,000,000, or, if a self-directed plan,
      whose investment decisions are made solely by persons that are accredited
      investors. 

14

	[ ] 	Category 5 	A private business development company as
      defined in Section 202(a)(22) of the Investment Advisers Act of
      1940 (United States). 
	 	  	  
	[ ] 	Category 6 	A director or executive officer of the Company.
    
	 	  	  
	[ ] 	Category 7 	A trust with total assets in excess of
      $5,000,000, not formed for the specific purpose of acquiring the Units,
      whose purchase is directed by a sophisticated person as described in Rule
      506(b)(2)(ii) under the 1933 Act. 
	 	  	  
	[ ] 	Category 8 	An entity in which all of the equity owners
      satisfy the requirements of one or more of the foregoing categories.
  

Note that the Subscriber claiming to
satisfy one of the above categories of Accredited Investor may be required to
supply the Company with a balance sheet, prior years' federal income tax returns
or other appropriate documentation to verify and substantiate the Subscriber's
status as an Accredited Investor.

If the Subscriber is an entity
which initialled Category 8 in reliance upon the Accredited Investor categories
above, state the name, address, total personal income from all sources for the
previous calendar year, and the net worth (exclusive of home, home furnishings
and personal automobiles) for each equity owner of the said entity: 

IN WITNESS WHEREOF, I have executed this Accredited Investor
Questionnaire.

	                                                                                                                                         	     Date:
      _____________________, 2009 
	Signature 	  
	  	  
	  	  
	Ahmad Doroudian
	  
	Print Name 	  
	  	  
	  	  
	President, CEO and
      Director 	  
	Title (if applicable) 	  

15

Schedule “D”

WARRANT CERTIFICATE

WARRANTS TO PURCHASE SHARES
OF COMMON STOCK OF NEUROKINE
PHARMACEUTICALS INC.

	Certificate No. ____________	500,000 Warrants 

This Warrant Certificate certifies that Ahmad Doroudian (the
“Subscriber”) is the owner of 500,000 Warrants (subject to adjustment as
provided herein), each of which represents the right to subscribe for and
purchase from Neurokine Pharmaceuticals Inc. (the “Company”), a share of the
Company’s the common stock, without par value, (the common stock, including any
stock into which it may be changed, reclassified or converted, is herein
referred to as the “common stock”) at the purchase price (the
“Exercise Price”) of US$0.005 per share on or before July 29,
2012. This Warrant Certificate represents only Warrants issued pursuant to the
Agreement, between the Company and the Subscriber.

THESE WARRANTS AND THE SECURITIES
ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, AND ARE SUBJECT TO CERTAIN RESTRICTIONS, CONTAINED IN
PARAGRAPH 6 HEREOF, WITH RESPECT TO THEIR TRANSFER.

     The Warrants represented by this
Warrant Certificate are subject to the following provisions, terms and
conditions:

1. EXERCISE OF WARRANTS

Exercise of Warrants. The Warrants may be exercised by
the Subscriber, in whole or in part (but not as to a fractional share of common
stock), by: 

	 	(a) 	
      surrender of this Warrant Certificate at the principal
      office of the Company with the appropriate form attached hereto as Exhibit
      A duly exercised, at any time within the period beginning on the date of
      the execution of this Warrant Certificate and expiring two (2) years
      thereafter (the “Exercise Period”), and

	 	 	 
	 	(b) 	
      by payment to the Company by certified check or bank
      draft of the purchase price for such shares.

The Company agrees that the shares of common stock so purchased
shall be and are deemed to be issued to the Subscriber as the record owner of
such shares of common stock as of the close of business on the date on which the
Warrant Certificate shall have been surrendered and payment made for such shares
of common stock. Certificates representing the shares of common stock so
purchased shall be delivered to the Subscriber promptly and in no event later
than ten (10) days after the Warrants shall have been so exercised, and, unless
the Warrants have expired, a new Warrant Certificate representing the number of
Warrants represented by the surrendered Warrant Certificate, if any, that shall
not have been exercised shall also be delivered to the Subscriber within such
time.

2. ADJUSTMENTS

Adjustments. The Exercise Price and the number of shares
of common stock issuable upon exercise of each Warrant shall be subject to
adjustment from time to time as follows: 

Stock Dividends; Stock Splits;
Reverse Stock Splits; Reclassifications. In case the Company shall (i)
subdivide its outstanding shares of common stock, (ii) combine its outstanding
shares of common stock into a smaller number of shares of any class of common
stock or (iii) issue any shares of its capital stock in a reclassification of
the common stock (including any such
reclassification in connection with a merger, consolidation or other business
combination in which the Company is the continuing corporation) (any one of
which actions is herein referred to as an “Adjustment Event”), the number
of shares of common stock purchasable upon exercise of each of the Warrants
immediately prior to the record date for such Adjustment Event shall be adjusted
so that the Subscriber shall thereafter be entitled to receive the number of
shares of common stock or other securities of the Company (such other securities
thereafter enjoying the rights of shares of common stock under this Warrant
Certificate) that such Subscriber would have owned or have been entitled to
receive after the happening of such Adjustment Event, had such Warrants been
exercised immediately prior to the happening of such Adjustment Event or any
record date with respect thereto. An adjustment made pursuant to this Section 2A
shall become effective immediately after the effective date of such Adjustment
Event retroactive to the record date, if any, for such Adjustment Event.

16

Adjustment of Exercise Price.
Whenever the number of shares of common stock purchasable upon the exercise of
each of the Warrants is adjusted pursuant to Section 2A, the Exercise Price for
each share of common stock payable upon exercise of each of the Warrants shall
be adjusted by multiplying such Exercise Price immediately prior to such
adjustment by a fraction, the numerator of which shall be the number of shares
of common stock purchasable upon the exercise of each of the Warrants
immediately prior to such adjustment, and the denominator of which shall be the
number of shares of common stock so purchasable immediately thereafter.

Statement on Warrant Certificates. The form of this
Warrant Certificate need not be changed because of any change in the Exercise
Price or in the number of kind of shares purchasable upon the exercise of a
Warrant and any Warrant Exercise Price and the same number and kind of shares as
are stated in this Warrant Certificate. However, the Company may at the time in
its sole discretion make any change in the form of the Warrant Certificate that
it may deem appropriate and that does not affect the substance thereof and any
Warrant Certificate thereafter issued, whether in exchange or substitution for
any outstanding Warrant Certificate or otherwise, may be in the form so
changed.

3. RESERVATION AND AUTHORIZATION OF COMMON STOCK

The Company covenants and agrees 

	 	(a) 	
      that all shares of common stock which may be issued upon
      the exercise of the Warrants represented by this Warrant Certificate will,
      upon issuance, be validly issued, fully paid and non-assessable and free
      of all insurance or transfer taxes, liens and charges with respect to the
      issue thereof,

	 	 	 
	 	(b) 	
      that during the Exercise Period, the Company will at all
      times have authorized, and reserved for the purpose of issue or transfer
      upon exercise of the Warrants evidenced by this Warrant Certificate,
      sufficient shares of common stock to provide for the exercise of the
      Warrants represented by this Warrant Certificate, and

	 	 	 
	 	(c) 	
      that the Company will take all such action as may be
      necessary to ensure that the shares of common stock issuable upon the
      exercise of the Warrants may be so issued without violation of any
      applicable law or regulation, or any requirements of any domestic
      securities exchange upon which any capital stock of the Company may be
      listed, provided, however, that nothing contained herein shall impose upon
      the Company any obligation to register the warrants evidenced by this
      Warrant Certificate or such common stock under applicable securities laws
      except as provided in the Subscription Agreement.

In the event that any securities of the Company other than the
common stock are issuable upon exercise of the Warrants, the Company will take
or refrain from taking any action referred to in clauses (A) through (c) of this
Section 3 as though such clauses applied, mutatis mutandis to such other
securities then issuable upon the exercise of the Warrants.

17

4. NO VOTING RIGHTS

This Warrant Certificate shall not entitle the Subscriber
hereof to any voting rights or other rights as a stockholder of the Company.

5. TRANSFER OF WARRANTS OR COMMON STOCK

The Subscriber agrees to be bound by the provisions contained
in the Agreement with respect to the limitations, including limitations imposed
for Securities Act compliance, on the transfer of the Warrants and the shares of
common stock issuable upon exercise of the Warrants.

6. RESTRICTIONS

(a) No Registration. The
Subscriber acknowledges and understands that the Warrants have not been
registered under the U.S. Securities Act or any other securities laws, are not
qualified for resale in the U.S., and that the Warrants must be held
indefinitely unless subsequently registered under the U.S. Securities Act or an
exemption from such registration is available. The Company has agreed to
register the shares underlying the Warrants for resale in the United States.

(b) Restrictions on Transfer.
The Issuer shall refuse to register any transfer of the Warrants or the shares
of common stock not made in accordance with the provisions of Regulation S of
the U.S. Securities Act, pursuant to registration under the U.S. Securities Act
or pursuant to an available exemption from registration.

(c) Legend. The Subscriber
acknowledges and understands that the certificates representing the Warrants or
the shares of common stock will be stamped with the following legends (or
substantially equivalent language) restricting transfer in the following
manner:

If the Subscriber is a Canadian
resident:

“THE SECURITIES REPRESENTED HEREBY
HAVE BEEN OFFERED IN AN OFFSHORE TRANSACTION TO A PERSON WHO IS NOT A U.S.
PERSON (AS DEFINED HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”).

NONE OF THE SECURITIES REPRESENTED
HEREBY HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES
LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR
INDIRECTLY, IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT
IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE
SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED
STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION S UNDER THE 1933
ACT.”

and 

18

“UNLESS PERMITTED UNDER SECURITIES
LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE
DATE THAT IS FOUR MONTHS AND A DAY AFTER THE LATER OF (i) THE PURCHASE OF THESE
SECURITIES AND (ii) THE DATE THE ISSUER BECAME A REPORTING ISSUER IN ANY
PROVINCE OR TERRITORY.”

If the Subscriber is a U.S.
resident:

“NONE OF THE SECURITIES REPRESENTED
HEREBY HAVE BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “1933 ACT”), OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO
REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED
STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE WITH THE
PROVISIONS OF REGULATION S UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE
CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED STATES” AND “U.S.
PERSON” ARE AS DEFINED BY REGULATION S UNDER THE 1933 ACT.”

and if the Shares are being sold
outside of the United States in accordance with Rule 904 of Regulation S, the
legend Regulations S legend may be removed by providing a declaration to the
Company’s registrar and transfer agent in such form as the Company may
prescribe, including an opinion of counsel that such sale complies with the
requirements of the U.S. Securities Act;

7. CLOSING OF BOOKS

The Company will at no time close its transfer books against
the transfer of any Warrants or of any shares of common stock or other
securities issuable upon the exercise of any Warrants in any manner which
interferes with the timely exercise of the Warrants.

8. WARRANTS EXCHANGEABLE, LOSS, THEFT

This Warrant Certificate is exchangeable, upon the surrender
hereof of any Subscriber at the office or agency of the Company referred to in
Section 1, for new Warrant, each such new Warrants to represent the right to
subscribe and purchase such number of shares of common stock as shall be
designated by said Subscriber hereof at the time of such surrender. Upon receipt
of evidence satisfactory to the Company of the loss, theft, destruction or
mutilation, or upon surrender or cancellation of this Warrant Certificate, the
Company will issue to the Subscriber a new Warrant Certificate of like tenor, in
lieu of this Warrant Certificate, representing the right to subscribe for and
purchase the number of shares of common stock which may be subscribed for and
purchased hereunder.

9. MERGERS, CONSOLIDATIONS, ETC.

If the Company shall merge or consolidate with another
corporation, the Subscriber thereafter has the right, upon exercise hereof and
payment of the Exercise Price, to receive solely the kind and amount of shares
of stock, other securities, property or cash or any combination thereof
receivable by a Subscriber of the number of shares of common stock for which
this Warrants might have been exercised immediately prior to such merger or
consolidation (assuming, if applicable, that the holder of such common stock
failed to exercise its rights of election, if any, as to the kind or amount of shares of stock, other securities,
property or cash or combination thereof receivable upon such merger or
consolidation).

19

In case of any reclassification or change of the shares of
common stock issuable upon exercise of these Warrants (other than elimination or
par value, a change in par value, or from par value to no par value, or as the
result of a subdivision or combination of shares (which is provided for
elsewhere herein), but including any reclassification of the shares of Common
stock into two or more classes or series of shares) or in case of any merger or
consolidation of another corporation into the Company in which the Company is
the surviving corporation and in which there is a reclassification or change of
the shares of common stock (other than a change in par value, or from par value
to no par value, or as a result of a subdivision or combination (which is
provided for elsewhere herein), but including any reclassification of the shares
of common stock underlying the Warrants, shall thereafter have the right, upon
exercise hereof and payment of the Exercise Price, to receive solely the kind
and amount of shares of stock (including, if applicable, common stock), other
securities, property or cash or any combination thereof receivable upon such
reclassification, change, merger or consolidation by a holder of the number of
shares of common stock for which these Warrants might have been exercised
immediately prior to such reclassification, change, merger or consolidation
(assuming, if applicable, that the holder of such common stock failed to
exercise its rights of election, if any, as to the kind or amount of shares of
stock, other securities, property or cash or combination thereof receivable upon
such reclassification, change, merger or consolidation).

10. RIGHTS AND OBLIGATIONS SURVIVE EXERCISE OF WARRANTS

The rights and obligations of the Company, of the Subscriber,
and of the holders of shares of common stock or other securities issued upon
exercise of the Warrants, contained in Sections 5 and 7 of this Warrant
Certificate shall survive the exercise of the Warrants.

	 	NEUROKINE PHARMACEUTICALS INC. 

   
	 	Ahmad Doroudian, President and CEO
  

20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]